midazolam has been researched along with methylprednisolone in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 11 (57.89) | 29.6817 |
| 2010's | 4 (21.05) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Sun, Y; Yan, Z | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Goodchild, CS; Marks, RL; Morley, SJ; Serrao, JM | 1 |
| Fu, K; Ochiai, N; Okutani, R; Yoshimura, Y | 1 |
| Remon, JP; Vermeire, A | 1 |
| Bueno Torres, A; García Enguita, MA; Girón Monbiela, JA; Ortega Lahuerta, P; Pardillos Calatayud, C; Rasal Miguel, S | 1 |
| Iwaki, H; Iwakiri, K; Kaneshiro, Y; Masada, T; Oda, Y; Ohashi, H; Takaoka, K | 1 |
| Gardner, JC; Ririe, DG; Turner, CS | 1 |
| Fukuda, S; Kishi, K; Sejima, H; Yamaguchi, S; Yasuda, K | 1 |
| Bogers, AJJC; Kinzig, M; Koch, BCP; Sörgel, F; Stolker, RJ; Tibboel, D; van Hoeven, MPJ; van Rosmalen, J; van Saet, A; Wildschut, ED; Zeilmaker-Roest, GA | 1 |
1 review(s) available for midazolam and methylprednisolone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for midazolam and methylprednisolone
| Article | Year |
|---|---|
Intrathecal midazolam for the treatment of chronic mechanical low back pain: a controlled comparison with epidural steroid in a pilot study.
Topics: Adult; Aged; Back Pain; Double-Blind Method; Female; Humans; Injections, Epidural; Injections, Spinal; Male; Methylprednisolone; Midazolam; Middle Aged; Pain Measurement; Pilot Projects; Prospective Studies; Surveys and Questionnaires; Time Factors | 1992 |
17 other study(ies) available for midazolam and methylprednisolone
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
First-principle, structure-based prediction of hepatic metabolic clearance values in human.
Topics: Computational Biology; Drug Discovery; Hepatocytes; Humans; Hydrogen-Ion Concentration; Liver; Metabolic Clearance Rate; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship; Sensitivity and Specificity; Software | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Perioperative management of a patient with severe bronchial asthma attack].
Topics: Anesthesia, Epidural; Anesthesia, Spinal; Colonic Neoplasms; Female; Humans; Intraoperative Complications; Methylprednisolone; Midazolam; Middle Aged; Music Therapy; Oxygen; Postoperative Complications; Status Asthmaticus | 1995 |
Compatibility and stability of ternary admixtures of morphine with haloperidol or midazolam and dexamethasone or methylprednisolone.
Topics: Chromatography, High Pressure Liquid; Dexamethasone; Drug Incompatibility; Drug Stability; Haloperidol; Hydrogen-Ion Concentration; Methylprednisolone; Midazolam; Morphine; Osmolar Concentration; Solubility; Temperature | 1999 |
[Discovery of an intra-arterial hydatid cyst during a diagnostic thoracotomy].
Topics: Adjuvants, Anesthesia; Adult; Anaphylaxis; Anti-Inflammatory Agents; Chlorpheniramine; Echinococcosis; Hemoptysis; Histamine Antagonists; Humans; Intraoperative Complications; Male; Methylprednisolone; Midazolam; Occupational Diseases; Preanesthetic Medication; Pulmonary Artery; Ranitidine; Thoracotomy | 2000 |
Increased hepatic cytochrome P4503A activity decreases the risk of developing steroid-induced osteonecrosis in a rabbit model.
Topics: Anesthetics, Intravenous; Animals; Antifungal Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Disease Models, Animal; Enzyme Induction; Excitatory Amino Acid Antagonists; Female; Femur Head Necrosis; Glucocorticoids; Incidence; Itraconazole; Liver; Methylprednisolone; Midazolam; Phenobarbital; Prevalence; Rabbits; Risk Factors | 2008 |
Vagal hypertonia and anesthesia in Angelman syndrome.
Topics: Adrenergic Agonists; Anaphylaxis; Androstanols; Anesthesia; Anesthetics, Inhalation; Anesthetics, Intravenous; Angelman Syndrome; Anti-Allergic Agents; Anti-Inflammatory Agents; Blood Pressure; Cardiopulmonary Resuscitation; Child; Diphenhydramine; Epinephrine; Female; Heart Arrest; Humans; Male; Methyl Ethers; Methylprednisolone; Midazolam; Monitoring, Physiologic; Neuromuscular Nondepolarizing Agents; Nitrous Oxide; Rocuronium; Sevoflurane; Tachycardia, Sinus; Vagus Nerve | 2008 |
Rotavirus-associated encephalopathy with a reversible splenial lesion.
Topics: Brain Diseases; Child, Preschool; Consciousness Disorders; Corpus Callosum; Diffusion Magnetic Resonance Imaging; Electroencephalography; Humans; Leukocytosis; Male; Methylprednisolone; Midazolam; Rotavirus Infections | 2009 |
In Vitro Recovery of Sufentanil, Midazolam, Propofol, and Methylprednisolone in Pediatric Cardiopulmonary Bypass Systems.
Topics: Anesthetics, Intravenous; Cardiopulmonary Bypass; Child; Humans; Methylprednisolone; Midazolam; Propofol; Sufentanil | 2020 |